양성 전립선 과형성에 대한 수술 후 3 개월 동안 환자보고 통증 및 증상 완화
양성 전립선 과형성에 대한 수술 후 3 개월 동안 환자보고 통증 및 증상 완화.
This is a prospective observational study in patients undergoing surgery for benign prostatic hyperplasia (BPH).
The purpose of the study is to investigate in great detail patients' recovery after surgery for BPH regarding pain, hematuria, urine leakage and use of pain-relieving medications for three months postoperatively. Patient-reported outcomes after three different surgical methods will be investigated: transurethral resection, transurethral vaporization and laser transurethral enucleation of the prostate (Green-LEP)
Research questions:
- How do patients rate their day-to-day pain during the first three months after surgery for BPH? How long does it take to be pain free?
- How does the patient estimate any day-to-day burning sensation during the first three months after surgery for BPH?
- How many painkilling tablets of a certain preparation and a certain strength take patients per day in the first three months after surgery for BPH?
- How long do patients have urinary leakage after surgery for BPH?
- Are the patients bothered by possible urine leakage and if so for how long after surgery for BPH?
- How long does one have macroscopic hematuria after surgery for BPH?
- How quickly are the patients' urinary tract problems affected according to the IPSS per month?
- Are the results on the above outcome measures different between the three TUR-P methods, TUV-P and Green LEP?
연구 개요
상태
상태
정황
정황
개입 / 치료
개입 / 치료
상세 설명
Design and selection:
This is a prospective multicenter observational study in which patients undergoing TUR-P, TUV-P and GreenLEP for BPH are included. The subjects will be followed up with a self-assessment form that is completed daily for three months and then sent to the responsible researchers. After this, the research subjects will be followed up with sent out IPSS forms after six months, and then annually for up to five years. These are sent in stamped envelopes.
Participants:
The study will include 500 patients who undergo surgery for BPH at Alingsås hospital, Sjukhusen i Väster and Sahlgrenska University Hospital, as well as possibly an additional urology clinic in the future. The inclusion criteria include men over 50 years of age with diagnosed BPH and LUTS who have an indication for surgery with any of the three methods studied.
Outcome measures:
- Pain and burning will be assessed using the NRS (numeric scale) between 0 and 10 where 0 is defined as "no pain/burning" and 10 is defined as "worst imaginable pain/burning". The researchers fill in this day-by-day for three months
- Use of pain-relieving medications will be investigated with a table in which the research subjects enter drug names and sum up the number of tablets taken per day.
- Urine leakage will be examined by the research subjects checking either "Yes" or "no" on the question of whether they have had urine leakage on a daily basis.
- If this urine leakage has bothered the research subjects, it is investigated by ticking either "Yes" or "No" daily as a follow-up question to the previous one.
- The duration of hematuria will be examined by the research subjects checking either "Yes" or "No" on the question of whether they have had blood in the urine daily
- The change in LUTS measured by IPSS will be used to measure patient-perceived outcomes at baseline, after four, eight and twelve weeks, after six months and then annually for five years.
Data Analysis:
Descriptive statistics will be used to compile the PROMs data. Changes over time will be analyzed using repeated measures (ANOVA). Differences in outcome measures between the three different methods will be analyzed with the Mann-Whitney test for continuous, independent data pairs, and the Chi-Square test for categorical variables.
Ethical considerations:
The study will be conducted in accordance with the Declaration of Helsinki, and all participants will give their informed consent. Ethical approval will be sought from the Ethical Review Authority (EPM)
Significance and clinical relevance:
The results of this study will provide important insights into how patient-reported outcomes after benign prostate surgery can be used to improve surgical outcomes and patient counseling. The results will also be able to be used to compare outcome measures between the three different treatments used for BPH. By highlighting the patient's perspective, care can be developed to better meet the patients' needs and expectations, and by determining a "normal course" regarding these outcome measures, the results can also be used in the future to identify patients who deviate from the expected recovery course.
연구 유형
연구 유형
등록 (추정된)
등록
연락처 및 위치
연구 연락처
연구 연락처
- 이름: Joakim BE Strömberg, MD, PhD
- 전화번호: 46-768-341-327
- 이메일: joakim.stromberg@vgregion.se
연구 장소
-
-
-
Alingsås, 스웨덴
- 모병
- Alingsås lasarett, department of general surgery, urology and orthopaedic surgery
-
Uddevalla, 스웨덴
- 아직 모집하지 않음
- NU sjukvården, Uddevalla sjukhus, department of urology
-
-
Sweden
-
Kungälv, Sweden, 스웨덴
- 아직 모집하지 않음
- Kungälvs sjukhus, department of urology
-
-
참여기준
자격 기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
샘플링 방법
연구 인구
Patients scheduled for surgery for benign prostatic hyperplasia
설명
Inclusion Criteria:
- Patients undergoing transurethral surgery for benign prostatic hyperplasia
- Singed informed consent to participate
Exclusion Criteria:
- Non-swedish speaking patients
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 관찰 모델: COHORT
- 시간 관점: PROSPECTIVE
그룹/코호트 수
코호트 및 개입
그룹/코호트그룹/코호트 |
개입 / 치료개입 / 치료 |
|---|---|
|
Patient treated by transurethral surgical procedure
Patients treated for BPH with surgery |
Thermocoagulation is used in contrast to the other methods Heat is used to vaporize prostate laser is used in contrast to the other methods |
연구는 무엇을 측정합니까?
주요 결과 측정
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Change in postoperative pain levels
기간: Day-by-day for three months
|
Day-by-day registration of pain by NRS (numeric response scale) for pain. Anchorpoints: 0 (no pain) to 10 (worst possible pain) |
Day-by-day for three months
|
2차 결과 측정
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Use of analgesics postoperatively
기간: Day-by-day for three months
|
Patients are to report all pain medication used day-by-day |
Day-by-day for three months
|
|
Duration of postoperative hematuria
기간: Day-by-day for three months
|
The patients register the incidence of hematuria day-by-day by checking either "yes" or "no" |
Day-by-day for three months
|
|
Duration of postoperative leakage of urine
기간: Day-by-day for three months
|
The patients record the incidence of leakage of urine day-by-day by checking either "yes" or "no" box |
Day-by-day for three months
|
|
Concerns about urine leakage
기간: Day-by-day for three months
|
If the patients have checked the box "yes" for urine leakage, they are asked to record if they are bothered by this leakage or not by checking either "yes" or "no" box |
Day-by-day for three months
|
|
Changes in Lower Urinary Tract Symptoms as measured by the IPSS questionnaire
기간: Month-by-month for 3 months
|
The patients are asked to complete the IPSS (International Prostatic Symptom Score) once a month. The IPSS is made up of 7 questions related to voiding symptoms. A score of 0 to 7 indicates mild symptoms, 8 to 19 indicates moderate symptoms and 20 to 35 indicates severe symptoms. |
Month-by-month for 3 months
|
공동 작업자 및 조사자
협력자
협력자
수사관
수사관
- 수석 연구원: Joakim BE Strömberg, MD, PhD, Sahlgrenska University Hospital
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
연구 시작
기본 완료 (추정된)
기본 완료
연구 완료 (추정된)
연구 완료
연구 등록 날짜
최초 제출
최초 제출
QC 기준을 충족하는 최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
처음 게시됨
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
마지막 업데이트 게시됨
QC 기준을 충족하는 마지막 업데이트 제출
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
기타 연구 ID 번호
- 2024-06211-01 EPM
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .